WATCH: What is a biosimilar, exactly?
(By Damian Garde for STAT) They’re meant to save money for the health care system, carve into pharma’s profits, and
Read More
Influenza A dominates as flu activity heightens: 5 things to know
(By Megan Knowles for Becker’s Hospital Review) As U.S. flu activity increases, the CDC has confirmed 43,071 positive respiratory specimens
Read MoreHealthcare costs threaten to throw your entire retirement way off track
According to a recent study from the Center for Retirement Research at Boston College, the average retiree age 75 and
Read MoreIf You’re Often Angry Or Irritable, You May Be Depressed
(By Nell Greenfieldboyce for NPR) When registered nurse Ebony Monroe of Houston went through a period of being quick to
Read MoreWinners And Losers Under Bold Trump Plan To Slash Drug Rebate Deals
(By Jay Hancock for Kaiser Health News) Few consumers have heard of the secret, business-to-business payments that the Trump administration
Read MoreLong-Term Trends in Employer-Based Coverage
(By Matthew Rae, Gary Claxton, Larry Levitt and Daniel McDermott for Kaiser Family Foundation) Employer-based health insurance is the most
Read MoreNew U.S. Experiments Aim To Create Gene-Edited Human Embryos
(By Rob Stein for NPR) A scientist in New York is conducting experiments designed to modify DNA in human embryos
Read MoreMedian estimated out-of-pocket costs for 30 specialty-tier drugs in 2019
(By Kelly Gooch for Becker’s Hospital Review) Medicare Part D beneficiaries with serious health conditions and not receiving low-income subsidies
Read MoreThe modern tragedy of fake cancer cures
(By Matthew Herper for STAT) So it happened again. An underreported story about a half-baked advance in cancer medicine caught
Read MoreIn bold new proposal, Trump administration pitches an end to certain drug rebates
(By Ike Swetlitz and Nicholas Florko for STAT) WASHINGTON — The Trump administration on Thursday put forth a long-awaited proposal
Read More